Come up with a name for your new list and we'll add to it:
Gliknik raised a round of funding on October 10, 2011. Investors include
National Cancer Institute.
Gliknik is a privately held biopharmaceutical company working to ease human suffering by creating new therapies for people living with cancer and immune disorders. Gliknik's founders combine scientifi…